Genpharmasec Ltd
₹ 2.25
-1.75%
24 Apr
- close price
About
Incorporated in 1992, Generic Pharmasec
Ltd deals in pharmaceutical activities /services and trades in equity shares[1]
Key Points
- Market Cap ₹ 125 Cr.
- Current Price ₹ 2.25
- High / Low ₹ 7.31 / 1.69
- Stock P/E 108
- Book Value ₹ 0.29
- Dividend Yield 0.00 %
- ROCE 2.01 %
- ROE 7.30 %
- Face Value ₹ 1.00
Pros
Cons
- Stock is trading at 7.72 times its book value
- Promoter holding has decreased over last quarter: -30.0%
- Promoter holding is low: 30.0%
- Company has a low return on equity of 4.14% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0.25 | 0.36 | 0.00 | 0.02 | 0.00 | 0.48 | 0.08 | 0.38 | 16.50 | 21.31 | 27.32 | 25.52 | 26.42 | |
0.38 | 0.35 | 0.04 | 0.40 | 0.11 | 0.54 | 0.11 | 0.46 | 15.85 | 20.12 | 27.84 | 25.26 | 26.21 | |
Operating Profit | -0.13 | 0.01 | -0.04 | -0.38 | -0.11 | -0.06 | -0.03 | -0.08 | 0.65 | 1.19 | -0.52 | 0.26 | 0.21 |
OPM % | -52.00% | 2.78% | -1,900.00% | -12.50% | -37.50% | -21.05% | 3.94% | 5.58% | -1.90% | 1.02% | 0.79% | ||
0.00 | 0.00 | 0.06 | 0.40 | 0.21 | 0.07 | 0.09 | 0.37 | 0.56 | 0.33 | 0.09 | 0.10 | 0.46 | |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.31 |
Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.02 |
Profit before tax | -0.13 | 0.01 | 0.02 | 0.02 | 0.10 | 0.01 | 0.06 | 0.29 | 1.21 | 1.51 | -0.44 | 0.28 | 0.34 |
Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 33.33% | 20.69% | 16.53% | 16.56% | 52.27% | -300.00% | |
-0.13 | 0.00 | 0.02 | 0.02 | 0.10 | 0.02 | 0.05 | 0.23 | 1.01 | 1.26 | -0.21 | 1.12 | 1.15 | |
EPS in Rs | -0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 | 0.07 | 0.01 | 0.02 | 0.02 | -0.00 | 0.02 | 0.02 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 53% |
5 Years: | 217% |
3 Years: | 16% |
TTM: | -1% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 86% |
3 Years: | 4% |
TTM: | 785% |
Stock Price CAGR | |
---|---|
10 Years: | 12% |
5 Years: | -26% |
3 Years: | -25% |
1 Year: | 21% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 4% |
3 Years: | 4% |
Last Year: | 7% |
Balance Sheet
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 6.52 | 6.52 | 6.52 | 6.52 | 6.52 | 0.33 | 0.33 | 21.69 | 21.69 | 27.69 | 27.69 | 27.69 | 27.69 |
Reserves | -7.59 | -7.58 | -7.56 | -7.54 | -7.44 | -1.23 | -1.19 | -1.57 | -4.15 | -7.02 | -12.32 | -12.36 | -11.56 |
1.39 | 1.10 | 1.06 | 1.07 | 0.98 | 1.05 | 0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 3.08 | 3.16 | |
0.00 | 0.60 | 0.19 | 0.00 | 0.00 | 0.44 | 0.02 | 1.51 | 7.21 | 7.15 | 6.28 | 1.46 | 5.40 | |
Total Liabilities | 0.32 | 0.64 | 0.21 | 0.05 | 0.06 | 0.59 | 0.15 | 21.63 | 24.75 | 27.82 | 21.65 | 19.87 | 24.69 |
0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.05 | 0.10 | 0.10 | 0.10 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.53 | 5.76 | 7.81 | 2.45 | 0.95 | 1.79 |
0.32 | 0.63 | 0.21 | 0.05 | 0.06 | 0.59 | 0.15 | 14.10 | 18.94 | 19.96 | 19.10 | 18.82 | 22.80 | |
Total Assets | 0.32 | 0.64 | 0.21 | 0.05 | 0.06 | 0.59 | 0.15 | 21.63 | 24.75 | 27.82 | 21.65 | 19.87 | 24.69 |
Cash Flows
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-0.10 | -0.02 | 0.01 | 0.03 | 0.10 | -0.05 | 0.14 | -6.40 | 1.39 | -2.13 | -2.34 | -3.23 | |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -10.42 | -4.01 | -1.41 | 0.42 | 0.54 | |
0.13 | 0.00 | -0.03 | 0.01 | -0.10 | 0.07 | -0.06 | 21.87 | 0.00 | 4.50 | 0.00 | 3.08 | |
Net Cash Flow | 0.03 | -0.02 | -0.02 | 0.04 | 0.00 | 0.02 | 0.08 | 5.04 | -2.62 | 0.96 | -1.93 | 0.39 |
Ratios
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 379.60 | 608.33 | 0.00 | 387.81 | 0.00 | 38.42 | 155.51 | 128.80 | 86.17 | 81.67 | ||
Inventory Days | 0.00 | 0.00 | 0.00 | 82.87 | 146.00 | 135.91 | 151.06 | |||||
Days Payable | 132.68 | 135.35 | 85.48 | 21.38 | ||||||||
Cash Conversion Cycle | 379.60 | 608.33 | 0.00 | 387.81 | 0.00 | 38.42 | 105.70 | 139.45 | 136.61 | 211.34 | ||
Working Capital Days | -14.60 | 0.00 | 0.00 | 45.62 | -136.88 | 941.32 | 117.24 | 144.39 | 149.77 | 207.67 | ||
ROCE % | -74.29% | 5.56% | 66.67% | 57.14% | -36.36% | 9.52% | 42.86% | 2.67% | 6.43% | 7.90% | -2.44% | 2.01% |
Documents
Announcements
- Submission Of Compliance Certificate Under Regulation 40(9) And 40(10) Of SEBI (LODR), 2015 For The Year Ended On March 31, 2024. 13h
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 18 Apr
- Compliance Certificate Under Regulation 7(3) Of The SEBI (LODR) Regulation, 2015 For The Year Ended 31St March, 2024. 8 Apr
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
5 Apr - Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulation, 2018 for the quarter ended March 31, 2024.
-
Announcement under Regulation 30 (LODR)-Updates on Acquisition
1 Apr - On acquisition of 70% stake in Derren Healthcare private Limited
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2000
from bse
Business Overview:[1]
GPL started as a manufacturer and trader of organic and inorganic chemicals, dyes and pigments and then shifted its business activities to buying, selling and distribution of pharmaceutical, medicinal and medicated preparations and also decided to deal in securities market. Currently, company is dealing in medical and diagnostics devices